These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20159702)

  • 1. [KIR/HLA ligand matching and acute rejection after kidney transplantation].
    Yu LX; Xiao F; Xiao LL; Luo M; Fu SJ; Wang YB; Miao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):288-91. PubMed ID: 20159702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
    Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIR/HLA ligand incompatibility in kidney transplantation.
    Kunert K; Seiler M; Mashreghi MF; Klippert K; Schönemann C; Neumann K; Pratschke J; Reinke P; Volk HD; Kotsch K
    Transplantation; 2007 Dec; 84(11):1527-33. PubMed ID: 18091530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation.
    Kreijveld E; van der Meer A; Tijssen HJ; Hilbrands LB; Joosten I
    Transplantation; 2007 Oct; 84(8):1045-51. PubMed ID: 17989611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.
    López-Alvarez MR; Moya-Quiles MR; Minguela A; Gil J; Miras M; Campillo JA; Díaz-Alderete MA; García-Alonso AM; Sánchez-Bueno F; Vicario JL; Muro M; Alvarez-López MR
    Transplantation; 2009 Aug; 88(3 Suppl):S54-61. PubMed ID: 19667963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
    Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
    Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Sobecks RM; Ball EJ; Askar M; Theil KS; Rybicki LA; Thomas D; Brown S; Kalaycio M; Andresen S; Pohlman B; Dean R; Sweetenham J; Macklis R; Bernhard L; Cherni K; Copelan E; Maciejewski JP; Bolwell BJ
    Bone Marrow Transplant; 2008 Apr; 41(8):709-14. PubMed ID: 18195688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades.
    Opelz G; Döhler B
    Transplantation; 2007 Jul; 84(2):137-43. PubMed ID: 17667803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
    Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
    Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X; Ishida H; Yamaguchi Y; Tanabe K
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical importance of HLA antigen matching in cadaveric kidney transplantation with high overall survival rates. The Manchester UK Kidney Transplant Team.
    Dyer PA; Martin S; Johnson RW
    Transplant Proc; 1992 Dec; 24(6):2454. PubMed ID: 1465827
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA class I (ABC) upregulation on peripheral blood CD3+/CD8+ T lymphocyte surface is a potential predictor of acute rejection in renal transplantation.
    Tian J; Shi WF; Zhang LW; Lu N; Cui XQ; Xian WH; Sun HB; Li EG; Geng LN; Zhang DZ; Zou X
    Transplantation; 2009 Dec; 88(12):1393-7. PubMed ID: 20029336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossmatch with donor skin: its correlation with early rejection of kidney transplants.
    Lasmar E; Távora E; Salomão A; Bambirra E; Penafiel P; Vilaça S
    Transplant Proc; 1992 Dec; 24(6):3070-1. PubMed ID: 1466059
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
    Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
    J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Panel reactive antibody screening and human leukocyte antigen typing in 1 700 cases of renal transplantation].
    Yu LX; Yao B; Ye GR; Du CF; Deng WF; Xu J; Ma JJ; Fu SJ; Xiao LL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):360-2. PubMed ID: 12390747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognostic analysis of KIR ligand mismatch in HLA-mismatched hematopoietic stem cell transplantation].
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):316-20. PubMed ID: 18844069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of HLA Matchmaker compatibility as predictor of graft survival and presence of Anti-HLA antibodies.
    Silva E; Alba A; Castro A; Carrascal M; Buckel E; Aguiló J; Herzog C; Calabrán L; Morales J; Fierro JA
    Transplant Proc; 2010; 42(1):266-9. PubMed ID: 20172326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.